Federal Circuit Hears Oral Argument In Dispute Over Gattex Patent

Mealey's (November 13, 2017, 12:57 PM EST) -- WASHINGTON, D.C. — The owner of a patent covering the short bowel syndrome (SBS) drug Gattex argued before the Federal Circuit U.S. Court of Appeals on Nov. 9 that the Patent...
To view the full article, register now.